Michael Fabrizio MD, FACS, CEO, Urology of Virginia, Professor of Urology Eastern Virginia Medical School
Advertisement
Articles by Michael Fabrizio MD, FACS, CEO, Urology of Virginia, Professor of Urology Eastern Virginia Medical School
Advertisement
Latest Updated Articles
- Long-term Survival with Immunotherapy in Advanced Prostate Cancer
September 4th 2019
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
4
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
5